Proyectos de ley › 89.ª Asamblea General

HF 794Retirado · SF 296 se hizo ley en su lugar · 7 de abril de 2021

Relating to the practice of pharmacy, including the prescription and administration of vaccines and collaborative pharmacy practice

Presentado por el comité Human Resources de la Cámara

Temas:Health careProfessional licensing

La misma legislación: HSB 91, SSB 1095, SF 296

Dónde está ahora

  1. Hecho: Presentado20 de enero de 2021
  2. Hecho: Subcomité20 de enero de 2021
  3. Hecho: Comité de la Cámara3 de marzo de 2021
  4. Hecho: Lo aprueba la Cámara7 de abril de 202189–2
  5. Se saltó: Comité del SenadoSe saltó
  6. Hecho: Lo aprueba el Senado17 de marzo de 202147–0
  7. Hecho: A gobernador(a)19 de mayo de 2021
  8. Hecho: Firmado como ley19 de mayo de 2021

SF 296 se hizo ley → La misma legislación se aprobó como SF 296, así que esta versión se dejó de lado. Ir a SF 296 ¿Qué es el embudo (funnel)?

Qué contiene

Resumen con IA Pharmacists would be allowed to order and give certain vaccines, like the COVID-19 shot, to people aged six and older. They could also perform quick tests and provide treatments for illnesses like the flu or strep throat during a patient visit. Additionally, pharmacists could work closely with other healthcare providers to manage a patient's medications, and insurance companies would be able to pay for these services. (Todavía no está traducido al español.)1

Lea la explicación oficial (en inglés)

This bill relates to the practice of pharmacy including the prescription and administration of vaccines and collaborative pharmacy practice. The bill adds immunizations and vaccinations for COVID-19 to the treatments that may be ordered and administered by a pharmacist to patients ages years and older pursuant to statewide protocols developed by the board of pharmacy in consultation with the department of public health. The bill allows a pharmacist to order and administer point-of-care testing and treatment for influenza, streptococcus A, and COVID-19 at the point of interaction between a pharmacist and a patient to patients ages six years and older. The bill also allows a pharmacist to order and administer point-of-care testing at the point of interaction between a pharmacist and a patient in response to a public health emergency to patients ages six years and older. The bill allows a pharmacist to engage in a collaborative pharmacy practice under a collaborative pharmacy practice agreement to provide patient care and drug therapy management services to a patient. The bill allows a health carrier to pay for a service provided by a pharmacist under a collaborative pharmacy practice agreement if the health benefit plan provides for payment or reimbursement for a service when the service is within the lawful scope of practice of a practitioner or pharmacist.

Cambiado después por las enmiendas H-1350, H-1349; vea Enmiendas.

Texto completo del proyecto (en inglés) · Qué cambió antes de aprobarse2

House subcommittee

Named January 20, 2021 (as HSB 91). On January 26, 2021 it recommended passage. Vote Total: 3-0.

Three legislators hear a bill first and recommend what the committee should do; it’s the best time to weigh in. How to take part

Lo que cambia del Código de Iowa (Iowa Code)

Crea§155A.47

Modifica§155A.46

Cómo funciona el Código3

Cabildeo

12 a favor · 10 en contra · 12 indecisos · Quiénes →

Family tree

Earlier and later bills are matched by wording or an identical title.

Tried before

This idea has been filed in an earlier General Assembly. None got through a chamber.

  • HSB 583 HSB 583
    88th General Assembly · Subcommittee recommends passage · very similar
    Cleared committee

Matched by wording or an identical title.